702 related articles for article (PubMed ID: 26281134)
21. Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation.
Cabello V; Margarit N; Díaz Pedrero M; Bernal G; Pereira P; Gentil MA
Transplant Proc; 2008 Nov; 40(9):2930-2. PubMed ID: 19010151
[TBL] [Abstract][Full Text] [Related]
22. [BK virus infections in pediatric kidney transplant recipients].
Mutlu D; Sağlık I; Koyun M; Comak E; Mutlu E; Uslu Gökçeoğlu A; Cağla Doğan S; Dinçkan A; Akbaş SH; Akkaya B; Akman S; Süleymanlar G; Colak D
Mikrobiyol Bul; 2013 Jul; 47(3):461-71. PubMed ID: 23971923
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and clinical course of BK virus nephropathy in pancreas after kidney transplant patients.
Duclos AJ; Krishnamurthi V; Lard M; Poggio E; Kleeman M; Winans C; Fatica R; Nurko S
Transplant Proc; 2006 Dec; 38(10):3666-72. PubMed ID: 17175362
[TBL] [Abstract][Full Text] [Related]
24. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis.
Huang G; Wang CX; Zhang L; Fei JG; Deng SX; Qiu J; Li J; Chen GD; Fu Q; Chen LZ
Diagn Microbiol Infect Dis; 2015 Jan; 81(1):21-6. PubMed ID: 25445121
[TBL] [Abstract][Full Text] [Related]
25. Temporal serum creatinine increase and exacerbation of tubulointerstitial inflammation during the first two months in resolving polyomavirus BK nephropathy.
Masutani K; Tsuchimoto A; Matsukuma Y; Kurihara K; Nishiki T; Kitada H; Tanaka M; Kitazono T; Tsuruya K
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():45-50. PubMed ID: 26031586
[TBL] [Abstract][Full Text] [Related]
26. A novel treatment regimen for BK viremia.
Zaman RA; Ettenger RB; Cheam H; Malekzadeh MH; Tsai EW
Transplantation; 2014 Jun; 97(11):1166-71. PubMed ID: 24531848
[TBL] [Abstract][Full Text] [Related]
27. BK virus nephropathy in renal transplant recipients.
Jamboti JS
Nephrology (Carlton); 2016 Aug; 21(8):647-54. PubMed ID: 26780694
[TBL] [Abstract][Full Text] [Related]
28. Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study.
Alméras C; Foulongne V; Garrigue V; Szwarc I; Vetromile F; Segondy M; Mourad G
Transplantation; 2008 Apr; 85(8):1099-104. PubMed ID: 18431228
[TBL] [Abstract][Full Text] [Related]
29. Intravenous immunoglobulin as rescue therapy for BK virus nephropathy.
Sharma AP; Moussa M; Casier S; Rehman F; Filler G; Grimmer J
Pediatr Transplant; 2009 Feb; 13(1):123-9. PubMed ID: 18822106
[TBL] [Abstract][Full Text] [Related]
30. Effects of intravenous immunoglobulin therapy and Fc gamma receptor polymorphisms on BK virus nephropathy in kidney transplant recipients.
Moon J; Chang Y; Shah T; Min DI
Transpl Infect Dis; 2020 Aug; 22(4):e13300. PubMed ID: 32323406
[TBL] [Abstract][Full Text] [Related]
31. BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients.
Westphal SG; Lyden ER; Langewisch ED; Miles CD
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28509373
[TBL] [Abstract][Full Text] [Related]
32. Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients.
Alméras C; Vetromile F; Garrigue V; Szwarc I; Foulongne V; Mourad G
Transpl Infect Dis; 2011 Apr; 13(2):101-8. PubMed ID: 21371220
[TBL] [Abstract][Full Text] [Related]
33. BK viral disease in renal transplantation.
Cannon RM; Ouseph R; Jones CM; Hughes MG; Eng M; Marvin MR
Curr Opin Organ Transplant; 2011 Dec; 16(6):576-9. PubMed ID: 22027587
[TBL] [Abstract][Full Text] [Related]
34. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation.
Elfadawy N; Flechner SM; Schold JD; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
Clin J Am Soc Nephrol; 2014 Mar; 9(3):553-61. PubMed ID: 24408118
[TBL] [Abstract][Full Text] [Related]
35. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy.
Araya CE; Lew JF; Fennell RS; Neiberger RE; Dharnidharka VR
Pediatr Transplant; 2006 Feb; 10(1):32-7. PubMed ID: 16499584
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
[TBL] [Abstract][Full Text] [Related]
37. Prospective study of BK virus infection and nephropathy during the first year after kidney transplantation.
Soleymanian T; Keyvani H; Jazayeri SM; Fazeli Z; Ghamari S; Mahabadi M; Chegeni V; Najafi I; Ganji MR
Iran J Kidney Dis; 2014 Mar; 8(2):145-51. PubMed ID: 24685738
[TBL] [Abstract][Full Text] [Related]
38. Elimination of BK viremia in renal transplant recipients by optimization of immunosuppressive medications without precipitating acute rejection.
Jha A; Ahmed W; Pakkyara A; Shaheen F; Al Salmi I
Saudi J Kidney Dis Transpl; 2018; 29(5):1073-1081. PubMed ID: 30381503
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and Risk Factors of BK Viremia and Clinical Impact of BK Virus Surveillance on Outcomes in Kidney Transplant Recipients: A Single-Center Cross-Sectional Study.
Ji J; Feng S; Jiang Y; Wang W; Zhang X
Exp Clin Transplant; 2019 Dec; 17(6):727-731. PubMed ID: 30995893
[TBL] [Abstract][Full Text] [Related]
40. BK virus nephropathy developing after renal transplantation and its treatment with ciprofloxacin: a case report.
Cekmen MB; Bakirdoven S; Sayan M; Yilmaz A
Transplant Proc; 2012 Dec; 44(10):3044-7. PubMed ID: 23195024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
